Individualizing Treatment for Adolescent Acne to Achieve Optimal Outcomes
To access this article, please choose from the options below
Dermik Laboratories, a business of Sanofi-Aventis U.S. LLC, provided funding to Peloton Advantage, LLC, in order to support the development of this article. Peloton Advantage assisted with fact-checking, editing, and preparing the manuscript for submission. The opinions expressed in the current article are those of the authors. The authors received no honoraria or other form of financial support related to the development of this manuscript. Lara A. Clayton, MPAS, PA-C, and Wynnis L. Tom, MD, have no financial conflicts of interest to report.
PII: S0891-5245(09)00177-1
doi:10.1016/j.pedhc.2009.06.003
© 2010 Published by Elsevier Inc.
